Dementia

Pharmaceutical companies in talks with NICE about access to Alzheimer’s drugs

Drug manufacturers Lilly and Eisai are in discussion with the National Institute for Health and Care Excellence to appeal the regulator’s rejection of the use of donanemab and lecanemab on the NHS for the third time in June 2025.…

MHRA report finds insufficient data on bladder anticholinergics dementia risk

The regulator also said limitations observed in several studies revealed that a “small increased risk” of dementia related to the use of bladder anticholinergic medicines cannot be ruled out entirely.…

Health news round-up: vaccination, testosterone and neighbourhood health

The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…

Stopping antipsychotics in patients with dementia reduces risk of fracture and delirium

The study’s lead author said the “findings provide reassurance” that stopping long-term antipsychotic treatment when no longer needed prevents harms.…

Health news round-up: ‘landmark’ long COVID trial results and are contraceptives linked to brain tumours?

The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…

Health news round-up: elecoglipron, antibiotic resistant E. coli and low blood pressure risk in frailty

The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…

Amyloid-targeting Alzheimer’s drugs ‘probably’ not effective

Authors of a Cochrane review said that any effect that donanemab and lecanemab have on cognitive function and dementia severity at 18 months was “trivial”.…

NICE opens consultation on previously-rejected Alzheimer’s treatments donanemab and lecanemab

The consultation follows an appeal by the manufacturers of donanemab and lecanemab after NICE said it would not recommend the drugs for NHS use for a third time.…

Health news round-up: antidepressants, hospital admissions and rheumatology workforce

A weekly summary of important developments in pharmacy and health news that you may have missed.…

Health news round-up: Alzheimer’s treatment, retatrutide results and kidney cancer guidelines

A weekly summary of important developments in pharmacy and health news that you may have missed.…